Clinical evidence and use of extrapolation in European biosimilar marketing authorizations
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Clinical evidence and use of extrapolation in European biosimilar marketing authorizations. / Druedahl, Louise C.; Vive Nielsen, Camilla; Hallgreen, Christine Erikstrup.
I: BioDrugs, 2023.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Druedahl, LC, Vive Nielsen, C & Hallgreen, CE 2023, 'Clinical evidence and use of extrapolation in European biosimilar marketing authorizations', BioDrugs.
APA
Druedahl, L. C., Vive Nielsen, C., & Hallgreen, C. E. (2023). Clinical evidence and use of extrapolation in European biosimilar marketing authorizations. Manuskript under forberedelse.
Vancouver
Druedahl LC, Vive Nielsen C, Hallgreen CE. Clinical evidence and use of extrapolation in European biosimilar marketing authorizations. BioDrugs. 2023.
Author
Bibtex
@article{4870e0cf55394bb3ba5fe8238032b17c,
title = "Clinical evidence and use of extrapolation in European biosimilar marketing authorizations",
author = "Druedahl, {Louise C.} and {Vive Nielsen}, Camilla and Hallgreen, {Christine Erikstrup}",
year = "2023",
language = "English",
journal = "BioDrugs",
issn = "1173-8804",
publisher = "Adis International Ltd",
}
RIS
TY - JOUR
T1 - Clinical evidence and use of extrapolation in European biosimilar marketing authorizations
AU - Druedahl, Louise C.
AU - Vive Nielsen, Camilla
AU - Hallgreen, Christine Erikstrup
PY - 2023
Y1 - 2023
M3 - Journal article
JO - BioDrugs
JF - BioDrugs
SN - 1173-8804
ER -
ID: 329423939